superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2019-12-31
- Valid until
- 2020-12-31
- Published
- 2020-02-19
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 6,085,700,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Eli Lilly and Company research and development: 5,595,000,000 United States dollar", as of 2019-12-31 (until 2020-12-31). Claim clm_7AE5F777CC93, https://asof.is/claim/clm_7AE5F777CC93, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947820000057/0000059478-20-000057-index.htm.
APA
AsOf. (2019). Eli Lilly and Company research and development: 5,595,000,000 United States dollar (as of 2019-12-31 (until 2020-12-31)) [Record clm_7AE5F777CC93]. Retrieved November 8, 2026, from https://asof.is/claim/clm_7AE5F777CC93 (source: https://www.sec.gov/Archives/edgar/data/59478/000005947820000057/0000059478-20-000057-index.htm)
BibTeX
@misc{asof_clm_7AE5F777CC93,
author = {AsOf},
title = {Eli Lilly and Company research and development: 5,595,000,000 United States dollar},
year = {2019},
howpublished = {\url{https://asof.is/claim/clm_7AE5F777CC93}},
note = {Claim clm\_7AE5F777CC93, as of 2019-12-31 (until 2020-12-31); source: https://www.sec.gov/Archives/edgar/data/59478/000005947820000057/0000059478-20-000057-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_7AE5F777CC93.md/v1/claims/clm_7AE5F777CC93submit a correction